ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
635 hedge funds and large institutions have $27.9B invested in Alexion Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 258 increasing their positions, 197 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1% less call options, than puts
Call options by funds: $218M | Put options by funds: $220M
4% less capital invested
Capital invested by funds: $29.1B → $27.9B (-$1.17B)
Holders
635
Holding in Top 10
12
Calls
$218M
Puts
$220M
Top Buyers
| 1 | +$476M | |
| 2 | +$153M | |
| 3 | +$110M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$106M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$102M |
Top Sellers
| 1 | -$466M | |
| 2 | -$350M | |
| 3 | -$211M | |
| 4 |
Jennison Associates
New York
|
-$161M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$91.7M |